In another study, phosphorylation at tyrosine 23 is required for ANXA2 activation, but knockdown of P-glycoprotein using small interference RNA in adriamycin-resistant breast cancer cell lines was found to significantly inhibit tyrosine phosphorylation of ANXA2. Here, ABCB1 is linked to breast cancer.